Brief: Mynd Analytics Received Letter From Nasdaq Confirming Regained Compliance
Aug 16 (Reuters) - MYnd Analytics Inc MYND.O :
* MYND ANALYTICS - ON AUG 14, RECEIVED LETTER FROM NASDAQ
CONFIRMING CO REGAINED COMPLIANCE WITH STOCKHOLDERS EQUITY
REQUIREMENT
Source text: (https://bit.ly/2OJ1ufP)
Further company coverage: MYND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns